• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Bad global culture?





Heard bad things about culture in their growing global access function? Insights? Experience?

Yeah I mean take it for what it's worth (one opinion) but the Global Access team is atrocious. Incredibly toxic and unintelligent individuals. Bad culture starts from the top down with DM.

Fortunately the US drives like 90% of our revenue so none of the bigwigs care all that much